References
- The EORTC International Antimicrobial Therapy Cooperative Group. Single v Multiple Daily Doses of Amikacin Combined with Ceftriaxone or Ceftazidime for Empirical Therapy of Fever in Granulocytopenic Cancer Patients. 31st ICAAC, Chicago, 1991; 1157, Abstract
- Winston D. J., Ho W. G., Bruckner D. A., Champlin R. E. Beta-Lactam Antibiotic Therapy in Febrile Granulocytopenic Patients. A Randomized Trial Comparing Cefoperazone plus Piperacillin, Ceftazidime plus Piperacillin, and Imipenem Alone. Annals of Internal Medicine 1991; 115: 849–859
- Menichetti F., Del Favero A. The role of Gram-positive therapy in the neutropenic patient. Journal of Antimicrobial Chemotherapy 1991; 27(Suppl. B.)51–60
- Denning D. W., Tucker R. M., Hanson L. H., et al. Treatment of invasive aspergillosis with itraconazole. American Journal of Medicine 1989; 86: 791–800
- Schmidt G. A., Horak D. A., Niland J. C., Duncan S. R., Forman S. J., Zaia J. A., The City of Hope-Stanford-Syntex CMV Study Group. A Randomized, Controlled Trial of Prophylactic Ganciclovir For Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants. The New England Journal of Medicine 1991; 324: 1005–1011
- Antman K. S., Griffin J. D., Elias A., et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. The New England Journal of Medicine 1988; 319: 593–598
- Wolff S. M. Monoclonal Antibodies and TheTreatment of Gram-Negative Bacteremia and Shock. The New England Journal of Medicine (editorial) 1991; 324: 486–487